Commonwealth Equity Services’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $525K | Sell |
8,052
-5,497
| -41% | -$358K | ﹤0.01% | 3096 |
|
|
2025
Q1 | $907K | Buy |
13,549
+2,037
| +18% | +$136K | ﹤0.01% | 2533 |
|
|
2024
Q4 | $636K | Sell |
11,512
-276
| -2% | -$15.2K | ﹤0.01% | 2770 |
|
|
2024
Q3 | $703K | Sell |
11,788
-326
| -3% | -$19.4K | ﹤0.01% | 2612 |
|
|
2024
Q2 | $771K | Sell |
12,114
-750
| -6% | -$47.7K | ﹤0.01% | 2481 |
|
|
2024
Q1 | $889K | Sell |
12,864
-40
| -0.3% | -$2.76K | ﹤0.01% | 2341 |
|
|
2023
Q4 | $712K | Sell |
12,904
-249
| -2% | -$13.7K | ﹤0.01% | 2417 |
|
|
2023
Q3 | $764K | Hold |
13,153
| – | – | ﹤0.01% | 2261 |
|
|
2023
Q2 | $708K | Sell |
13,153
-475
| -3% | -$25.6K | ﹤0.01% | 2353 |
|
|
2023
Q1 | $541 | Hold |
13,628
| – | – | ﹤0.01% | 2487 |
|
|
2022
Q4 | $548K | Buy |
13,628
+500
| +4% | +$20.1K | ﹤0.01% | 2394 |
|
|
2022
Q3 | $421K | Buy |
13,128
+785
| +6% | +$25.2K | ﹤0.01% | 2557 |
|
|
2022
Q2 | $366K | Buy |
12,343
+100
| +0.8% | +$2.97K | ﹤0.01% | 2652 |
|
|
2022
Q1 | $344K | Buy |
12,243
+765
| +7% | +$21.5K | ﹤0.01% | 2852 |
|
|
2021
Q4 | $528K | Buy |
+11,478
| New | +$528K | ﹤0.01% | 2476 |
|
|
2017
Q1 | – | Sell |
-4,668
| Closed | -$283K | – | 2416 |
|
|
2016
Q4 | $283K | Sell |
4,668
-180
| -4% | -$10.9K | ﹤0.01% | 1807 |
|
|
2016
Q3 | $322K | Buy |
4,848
+279
| +6% | +$18.5K | ﹤0.01% | 1657 |
|
|
2016
Q2 | $255K | Buy |
+4,569
| New | +$255K | ﹤0.01% | 1776 |
|